IBDEI3GU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,58294,0)
 ;;=E09.359^^272^2905^30
 ;;^UTILITY(U,$J,358.3,58294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58294,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58294,1,4,0)
 ;;=4^E09.359
 ;;^UTILITY(U,$J,358.3,58294,2)
 ;;=^5002561
 ;;^UTILITY(U,$J,358.3,58295,0)
 ;;=H52.4^^272^2906^57
 ;;^UTILITY(U,$J,358.3,58295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58295,1,3,0)
 ;;=3^Presbyopia
 ;;^UTILITY(U,$J,358.3,58295,1,4,0)
 ;;=4^H52.4
 ;;^UTILITY(U,$J,358.3,58295,2)
 ;;=^98095
 ;;^UTILITY(U,$J,358.3,58296,0)
 ;;=H01.004^^272^2906^6
 ;;^UTILITY(U,$J,358.3,58296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58296,1,3,0)
 ;;=3^Blepharitis,Left Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,58296,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,58296,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,58297,0)
 ;;=H01.005^^272^2906^5
 ;;^UTILITY(U,$J,358.3,58297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58297,1,3,0)
 ;;=3^Blepharitis,Left Lower Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,58297,1,4,0)
 ;;=4^H01.005
 ;;^UTILITY(U,$J,358.3,58297,2)
 ;;=^5133380
 ;;^UTILITY(U,$J,358.3,58298,0)
 ;;=H02.105^^272^2906^24
 ;;^UTILITY(U,$J,358.3,58298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58298,1,3,0)
 ;;=3^Ectropion,Left Lower Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,58298,1,4,0)
 ;;=4^H02.105
 ;;^UTILITY(U,$J,358.3,58298,2)
 ;;=^5133409
 ;;^UTILITY(U,$J,358.3,58299,0)
 ;;=H02.104^^272^2906^25
 ;;^UTILITY(U,$J,358.3,58299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58299,1,3,0)
 ;;=3^Ectropion,Left Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,58299,1,4,0)
 ;;=4^H02.104
 ;;^UTILITY(U,$J,358.3,58299,2)
 ;;=^5004305
 ;;^UTILITY(U,$J,358.3,58300,0)
 ;;=H02.101^^272^2906^27
 ;;^UTILITY(U,$J,358.3,58300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58300,1,3,0)
 ;;=3^Ectropion,Right Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,58300,1,4,0)
 ;;=4^H02.101
 ;;^UTILITY(U,$J,358.3,58300,2)
 ;;=^5004303
 ;;^UTILITY(U,$J,358.3,58301,0)
 ;;=H02.102^^272^2906^26
 ;;^UTILITY(U,$J,358.3,58301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58301,1,3,0)
 ;;=3^Ectropion,Right Lower Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,58301,1,4,0)
 ;;=4^H02.102
 ;;^UTILITY(U,$J,358.3,58301,2)
 ;;=^5133407
 ;;^UTILITY(U,$J,358.3,58302,0)
 ;;=H04.121^^272^2906^23
 ;;^UTILITY(U,$J,358.3,58302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58302,1,3,0)
 ;;=3^Dry Eye Syndrome,Right Lacrimal Gland
 ;;^UTILITY(U,$J,358.3,58302,1,4,0)
 ;;=4^H04.121
 ;;^UTILITY(U,$J,358.3,58302,2)
 ;;=^5004463
 ;;^UTILITY(U,$J,358.3,58303,0)
 ;;=H04.122^^272^2906^22
 ;;^UTILITY(U,$J,358.3,58303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58303,1,3,0)
 ;;=3^Dry Eye Syndrome,Left Lacrimal Gland
 ;;^UTILITY(U,$J,358.3,58303,1,4,0)
 ;;=4^H04.122
 ;;^UTILITY(U,$J,358.3,58303,2)
 ;;=^5004464
 ;;^UTILITY(U,$J,358.3,58304,0)
 ;;=H43.811^^272^2906^80
 ;;^UTILITY(U,$J,358.3,58304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58304,1,3,0)
 ;;=3^Vitreous Degeneration,Right Eye
 ;;^UTILITY(U,$J,358.3,58304,1,4,0)
 ;;=4^H43.811
 ;;^UTILITY(U,$J,358.3,58304,2)
 ;;=^5005953
 ;;^UTILITY(U,$J,358.3,58305,0)
 ;;=H43.812^^272^2906^79
 ;;^UTILITY(U,$J,358.3,58305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58305,1,3,0)
 ;;=3^Vitreous Degeneration,Left Eye
 ;;^UTILITY(U,$J,358.3,58305,1,4,0)
 ;;=4^H43.812
 ;;^UTILITY(U,$J,358.3,58305,2)
 ;;=^5005954
 ;;^UTILITY(U,$J,358.3,58306,0)
 ;;=H25.89^^272^2906^9
 ;;^UTILITY(U,$J,358.3,58306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58306,1,3,0)
 ;;=3^Cataract,Age-Related NEC
 ;;^UTILITY(U,$J,358.3,58306,1,4,0)
 ;;=4^H25.89
